J Travel Med. 2005 Jan-Feb;12(1):14-8
Postexposure chemoprophylaxis for occupational exposure to human immunodeficiency virus in traveling health care workers.
Uslan DZ, Virk A.
Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA


Curr HIV/AIDS Rep. 2004 Dec;1(4):159-65
Management of Occupational and Nonoccupational Postexposure HIV Prophylaxis.
Katz MH, Gerberding JL.
San Francisco Department of Public Health, 101 Grove Street, San Francisco, CA 94102, USA.


Clin Infect Dis. 2004 Aug 1;39(3):395-401. Epub 2004 Jul 16.
Two drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIV.
Bassett IV, Freedberg KA, Walensky RP.
Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA


Unfallchirurg. 2004 Feb;107(2):129-142
Postexposure prevention after occupational exposure to HBV, HCV and HIV
Sarrazin U, Brodt R, Sarrazin C, Zeuzem S.
Klinik und Poliklinik fur Innere Medizin II, Universitatskliniken des Saarlandes, Homburg/Saar, Germany.


Am J Emerg Med. 2003 Jul;21(4):309-12
HIV postexposure prophylaxis practices by US ED practitioners.
Merchant RC, Keshavarz R.
Department of Emergency Medicine, Mount Sinai School of Medicine, New York, NY, USA.


J Am Dent Assoc. 2002 Dec;133(12):1619-26
Use of HIV postexposure prophylaxis by dental health care personnel: an overview and updated recommendations.
Cleveland JL, Barker L, Gooch BF, Beltrami EM, Cardo D; National Surveillance System for Health Care Workers Group of the Centers for Disease Control and Prevention.
Division of Oral Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Chamblee, GA 30341, USA.


Infect Control Hosp Epidemiol. 2002 Jun;23(6):345-8
Transmission of drug-resistant HIV after an occupational exposure despite postexposure prophylaxis with a combination drug regimen.
Beltrami EM, Luo CC, de la Torre N, Cardo DM.
Prevention and Evaluation Branch, Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA


CMAJ. 2001 Aug 21;165(4):445-51
Transmission and postexposure management of bloodborne virus infections in the health care setting: where are we now?
Moloughney BW.
Department of Public Health Sciences, University of Toronto, Ont.


Infect Control Hosp Epidemiol. 2000 Aug;21(8):529-31
Transient detection of plasma HIV-1 RNA during postexposure prophylaxis.
Puro V, Calcagno G, Anselmo M, Benvenuto G, Trabattoni D, Clerici M, Ippolito G.
IRCCS Lazzaro Spallanzani, Roma, Italy


N Engl J Med. 1997 Nov 20;337(21):1485-90.
A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.
Cardo DM, Culver DH, Ciesielski CA, Srivastava PU, Marcus R, Abiteboul D, Heptonstall J, Ippolito G, Lot F, McKibben PS, Bell DM.
National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.


Ann Intern Med. 1993 Jun 15;118(12):913-9.
Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. The CDC Cooperative Needlestick Surveillance Group.
Tokars JI, Marcus R, Culver DH, Schable CA, McKibben PS, Bandea CI, Bell DM.
Hospital Infections Program, Centers for Disease Control and Prevention, Atlanta, Georgia



Letzte Änderung 08/2005